News & Articles

Tropical Fever Panel a syndromic PCR test, targets the causes of tropical fever infections

The study was commissioned and funded by the National Institute for Health and Care Research (NIHR), and its leading partners were The University of Manchester, Northern Care Alliance NHS Foundation Trust and Warwick Medical School’s Clinical Trials Unit, who specialize in research in emergency and critical care

T2 Biosystems announces plans to license its proprietary technology to accelerate the broad adoption of direct-from-whole-blood diagnostics, generate non-dilutive capital, and create a new royalty revenue stream

Series A financing highlights the potential impact of Abselion’s technology for life science research and bioprocess development

Research at Karl Landsteiner University of Health Sciences offers new insight in brain connectivity and development

The PATHWAY HER2 (4B5) test helps identify patients with previously treated, unresectable or metastatic HER2-positive biliary tract cancer (BTC) who may be eligible for treatment with ZIIHERA

The expansion enhances Abzena’s extensive bioassay offering, providing customers with a more comprehensive, streamlined, and cost-effective way to access critical data faster

Collaboration to advance newborn genetic screening, leveraging cutting-edge genomics research and laboratory expertise to detect rare conditions early

GERSTEL joins AAT’s portfolio of leading brands, including Skalar Analytical, LCTech, PromoChrom, EST Analytical, and tsHR, boosting global reach and expanding product and service offerings

Biodesix and Memorial Sloan Kettering have joined forces to advance oncology diagnostics

The latest updates support cryo-correlative light and electron microscopy (cryo-CLEM) and allows researchers to investigate samples at cryogenic temperatures down to <–195°C

The strategic partnership combines cutting-edge molecular profiling technology with unparalleled biospecimen and tissue profiling services

Aims to streamline clinical lab workflows with integrated tissue enrichment and nucleic acid purification solutions

New laboratory operating system revealed at the 2024 AMP Conference in Vancouver, Canada

Glox Therapeutics, involved in the development of precision antibiotic therapies based on naturally occurring bacteriocins, announced it has secured £1 million in grant funding from PACE (Pathways to Antimicrobial Clinical Efficacy).

Highlighting the impact of ctDNA and NGS for advancing cancer diagnostics and personalized treatment

Find out how CLINICAL24 supporter, the IBMS, has been addressing challenges for biomedical scientists through training, education, and advocacy for over 100 years

This collaboration brings new possibilities for consistent, high-purity cfDNA isolation

Sapio Sciences, the science-aware™ lab informatics platform, has entered a co-marketing agreement with Waters Corporation to enhance data integrity, workflow efficiency, and laboratory productivity

This new development will allow mRNA therapies to be manufactured in Poland for drug developers to treat COVID, potential forms of cancer, and more

Research results highlight how the Idylla™ System allows for the analysis of small biological samples, including cytological specimens, giving healthcare providers critical information within hours so they can make timely treatment decisions

New guidelines for SARS-CoV-2 genomic surveillance aim to standardize NGS practices

New proprietary assembly technology pairs with groundbreaking complex DNA synthesis platform to deliver sequence-perfect clonal DNA as long as 5 kb

Promega and QuantumCyte sign co-marketing agreement aimed at enhancing the workflow solutions available to clinical laboratories

inCerebro enhances CDD's capabilities in managing, sharing, and analysing complex research data, from its proprietary inCerebro MIND platform (Modelling with Intelligence for Novel Drugs).